Provided by Tiger Fintech (Singapore) Pte. Ltd.

Coherus BioSciences

1.02
-0.0800-7.27%
Post-market: 1.020.00000.00%18:47 EDT
Volume:1.27M
Turnover:1.33M
Market Cap:118.21M
PE:4.10
High:1.12
Open:1.08
Low:1.01
Close:1.10
Loading ...
Jun 17, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 17, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 17, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 16, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 16, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 16, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 16, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 16, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 18, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 06, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals